KUWAHARA, Mitsuhiro, ARAI, Morio
openaire +2 more sources
Good metabolic control is associated with decreased circulating factor VIIa- antithrombin complexes in type 2 diabetes: a cross-sectional study. [PDF]
Gastoł J +4 more
europepmc +1 more source
Efficacy and Safety Analyses of Recombinant Factor VIIa in Severe Post-Partum Hemorrhage. [PDF]
Caram-Deelder C +19 more
europepmc +1 more source
Recombinant Factor VIIa : A Universal Haemostatic Agent?
Gill R, Herbertson M
doaj
The anticoagulant effects of milvexian, a novel small molecule factor XIa inhibitor, are neutralized by activated prothrombin complex concentrates and recombinant factor VIIa in human plasma and whole blood in vitro. [PDF]
Bunce M, Huang Devine Z, Chintala M.
europepmc +1 more source
CT-001, a novel fast-clearing factor VIIa, enhanced the hemostatic activity in postpartum samples. [PDF]
Sim DS +8 more
europepmc +1 more source
Therapeutic doses of recombinant factor VIIa in hemophilia generates thrombin in platelet-dependent and -independent mechanisms. [PDF]
Keshava S +3 more
europepmc +1 more source
Use of Factor VIIa and Anti-inhibitor Coagulant Complex in Pediatric Cardiac Surgery Patients. [PDF]
Carroll RB +4 more
europepmc +1 more source
The evolution of factor VIIa in the treatment of bleeding in haemophilia with inhibitors. [PDF]
Meeks SL, Leissinger CA.
europepmc +1 more source

